The ‘China Plus One’ gold rush: 3 Indian pharma stocks making the most of it
India's CDMO sector is rapidly expanding, driven by global pharma's shift away from China, strong regulatory compliance, cost-efficiency, and government incentives. Companies like Innova Captab, Piramal Pharma, and Syngene International are leading this growth with strategic investments and rising global demand.
India's CDMO sector is rapidly expanding, driven by global pharma's shift away from China, strong regulatory compliance, cost-efficiency, and government incentives. Companies like Innova Captab, Piramal Pharma, and Syngene International are leading this growth with strategic investments and rising global demand.
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
